← Evidence map

ArticleNaunyn-Schmiedeberg's archives of pharmacology2026

Safety profile of olanzapine/samidorphan: focus on metabolic risks, opioid-related effects, and novel adverse events identified.

Xiangyu Li et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 41313444